BNTC

Benitec Biopharma Inc. · NASDAQ · Healthcare · USD · 10-K for 2026, filed 2026-09-14

Figures on this page computed 2026-11-08 00:12 UTC

Last close

9.54USD

Market data, 2026-11-06

BNTC: weekly closes from 12.79 on 2025-11-07 to 9.54 on 2026-11-06, a move of -25.4%. Prices in USD.

Weekly closes, 2025-11-07 to 2026-11-06

Over that span: -25.4%

Except where said otherwise: 10-K for 2026, filed 2026-09-14

  • n/aP/E

    We do not hold this figure for this company, so there is nothing to place.

    Price / Earnings per Share (diluted)

    Source
    computed
    Fiscal year
    2026
    Accession
    0001193125-26-390570
    Reported in
    USD
    • computed
    • 10-K for 2026, filed 2026-09-14

    The filing itself

  • n/aROIC

    We do not hold this figure for this company, so there is nothing to place.

    NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash

    Source
    computed
    Fiscal year
    2026
    Accession
    0001193125-26-390570
    Reported in
    USD
    • 10-K for 2026, filed 2026-09-14
    • 10-K for 2026, filed 2026-09-14
    • 10-K for 2026, filed 2026-09-14
    • 10-K for 2026, filed 2026-09-14
    • 10-K for 2026, filed 2026-09-14
    • 10-K for 2026, filed 2026-09-14

    The filing itself

  • n/aNet margin

    We do not hold this figure for this company, so there is nothing to place.

    Net Income / Revenue x 100

    Source
    computed
    Fiscal year
    2026
    Accession
    0001193125-26-390570
    Reported in
    USD
    • 10-K for 2026, filed 2026-09-14
    • 10-K for 2026, filed 2026-09-14

    The filing itself

  • n/aFCF margin

    We do not hold this figure for this company, so there is nothing to place.

    Free Cash Flow / Revenue x 100

    Source
    computed
    Fiscal year
    2026
    Accession
    0001193125-26-390570
    Reported in
    USD
    • 10-K for 2026, filed 2026-09-14
    • 10-K for 2026, filed 2026-09-14

    The filing itself

  • n/aDebt/equity

    We do not hold this figure for this company, so there is nothing to place.

    Total Debt / Shareholders' Equity

    Source
    computed
    Fiscal year
    2026
    Accession
    0001193125-26-390570
    Reported in
    USD
    • 10-K for 2026, filed 2026-09-14
    • 10-K for 2026, filed 2026-09-14

    The filing itself

  • n/aDividend yield

    We do not hold this figure for this company, so there is nothing to place.

    Source
    computed
    Taken on
    2026-11-07
    Reported in
    USD
    • computed

The filed years, as a table

10

Each line is 100 at 2013-06-30, the first year we hold.

Filed yearSalesShares in issue
2013-06-30100.0n/a
2014-06-30189.5n/a
2019-06-302,418.3n/a
2020-06-3020.2n/a
2021-06-3011.7100.0
2022-06-3014.5190.2
2023-06-3014.9548.5
2024-06-300.07,268.1
2025-06-30n/a14,330.6
2026-06-30n/a18,426.4
How sales was got
Source
filed
Statement
income
Fiscal year
2026
Accession
0001193125-26-390570
Reported in
USD

The filing itself

How shares in issue was got
Source
filed
Statement
income
Fiscal year
2026
Accession
0001193125-26-390570
Reported in
USD

The filing itself

Figures behind the shape

Growth

-20.1%

faster is higher, placed against 4,950 companies as of 2026-11-07

  • Five-year revenue growth raten/a

    We do not hold this figure for this company, so there is nothing to place.

    Source
    computed
    Taken on
    2026-11-07
    Reported in
    USD
    • computed
  • Five-year EPS growth raten/a

    We do not hold this figure for this company, so there is nothing to place.

    Source
    computed
    Taken on
    2026-11-07
    Reported in
    USD
    • computed
  • One-year change in net income-20.1%
    Source
    computed
    Taken on
    2026-11-07
    Reported in
    USD
    • computed

Returns on capital

-25.7%

higher is higher, placed against 5,089 companies as of 2026-11-07

  • Return on invested capitaln/a

    We do not hold this figure for this company, so there is nothing to place.

    NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash

    Source
    computed
    Fiscal year
    2026
    Accession
    0001193125-26-390570
    Reported in
    USD
    • 10-K for 2026, filed 2026-09-14
    • 10-K for 2026, filed 2026-09-14
    • 10-K for 2026, filed 2026-09-14
    • 10-K for 2026, filed 2026-09-14
    • 10-K for 2026, filed 2026-09-14
    • 10-K for 2026, filed 2026-09-14

    The filing itself

  • Return on equity-25.7%

    Net Income / Shareholders' Equity x 100

    Source
    computed
    Fiscal year
    2026
    Accession
    0001193125-26-390570
    Reported in
    USD
    • 10-K for 2026, filed 2026-09-14
    • 10-K for 2026, filed 2026-09-14

    The filing itself

  • Return on assets-24.9%

    Net Income / Total Assets x 100

    Source
    computed
    Fiscal year
    2026
    Accession
    0001193125-26-390570
    Reported in
    USD
    • 10-K for 2026, filed 2026-09-14
    • 10-K for 2026, filed 2026-09-14

    The filing itself

Margins

n/a

We do not hold this figure for this company, so there is nothing to place.

wider is higher, with no cohort held

  • Gross marginn/a

    We do not hold this figure for this company, so there is nothing to place.

    Gross Profit / Revenue x 100

    Source
    computed
    Fiscal year
    2026
    Accession
    0001193125-26-390570
    Reported in
    USD
    • 10-K for 2026, filed 2026-09-14
    • 10-K for 2026, filed 2026-09-14

    The filing itself

  • Operating marginn/a

    We do not hold this figure for this company, so there is nothing to place.

    Operating Income / Revenue x 100

    Source
    computed
    Fiscal year
    2026
    Accession
    0001193125-26-390570
    Reported in
    USD
    • 10-K for 2026, filed 2026-09-14
    • 10-K for 2026, filed 2026-09-14

    The filing itself

  • Net marginn/a

    We do not hold this figure for this company, so there is nothing to place.

    Net Income / Revenue x 100

    Source
    computed
    Fiscal year
    2026
    Accession
    0001193125-26-390570
    Reported in
    USD
    • 10-K for 2026, filed 2026-09-14
    • 10-K for 2026, filed 2026-09-14

    The filing itself

  • Free cash flow marginn/a

    We do not hold this figure for this company, so there is nothing to place.

    Free Cash Flow / Revenue x 100

    Source
    computed
    Fiscal year
    2026
    Accession
    0001193125-26-390570
    Reported in
    USD
    • 10-K for 2026, filed 2026-09-14
    • 10-K for 2026, filed 2026-09-14

    The filing itself

Price

2.5x

cheaper is higher, placed against 4,482 companies as of 2026-11-07

  • Price to earningsn/a

    We do not hold this figure for this company, so there is nothing to place.

    Price / Earnings per Share (diluted)

    Source
    computed
    Fiscal year
    2026
    Accession
    0001193125-26-390570
    Reported in
    USD
    • computed
    • 10-K for 2026, filed 2026-09-14

    The filing itself

  • Price to book2.5x

    Price / Book Value per Share, where BVPS = Shareholders' Equity / Diluted Shares

    Source
    computed
    Fiscal year
    2026
    Accession
    0001193125-26-390570
    Reported in
    USD
    • computed
    • 10-K for 2026, filed 2026-09-14
    • computed
    • 10-K for 2026, filed 2026-09-14

    The filing itself

  • EV to EBITDAn/a

    We do not hold this figure for this company, so there is nothing to place.

    Enterprise Value / EBITDA, where EV = Market Cap + Total Debt - Cash

    Source
    computed
    Fiscal year
    2026
    Accession
    0001193125-26-390570
    Reported in
    USD
    • computed
    • 10-K for 2026, filed 2026-09-14
    • 10-K for 2026, filed 2026-09-14
    • 10-K for 2026, filed 2026-09-14
    • 10-K for 2026, filed 2026-09-14

    The filing itself

  • Price to sales ration/a

    We do not hold this figure for this company, so there is nothing to place.

    Market Cap / Revenue, where Market Cap = Price x Diluted Shares

    Source
    computed
    Fiscal year
    2026
    Accession
    0001193125-26-390570
    Reported in
    USD
    • computed
    • 10-K for 2026, filed 2026-09-14
    • 10-K for 2026, filed 2026-09-14

    The filing itself

Safety

34.00

safer is higher, placed against 4,231 companies as of 2026-11-07

  • Debt to equityn/a

    We do not hold this figure for this company, so there is nothing to place.

    Total Debt / Shareholders' Equity

    Source
    computed
    Fiscal year
    2026
    Accession
    0001193125-26-390570
    Reported in
    USD
    • 10-K for 2026, filed 2026-09-14
    • 10-K for 2026, filed 2026-09-14

    The filing itself

  • Current ratio34.00

    Current Assets / Current Liabilities

    Source
    computed
    Fiscal year
    2026
    Accession
    0001193125-26-390570
    Reported in
    USD
    • 10-K for 2026, filed 2026-09-14
    • 10-K for 2026, filed 2026-09-14

    The filing itself

  • Interest coveragen/a

    We do not hold this figure for this company, so there is nothing to place.

    Operating Income / Interest Expense

    Source
    computed
    Fiscal year
    2026
    Accession
    0001193125-26-390570
    Reported in
    USD
    • 10-K for 2026, filed 2026-09-14
    • 10-K for 2026, filed 2026-09-14

    The filing itself

  • Altman Z-Scoren/a

    We do not hold this figure for this company, so there is nothing to place.

    1.2 x A + 1.4 x B + 3.3 x C + 0.6 x D + 1.0 x E (A=WC/TA, B=RE/TA, C=EBIT/TA, D=MktCap/TL, E=Rev/TA)

    Source
    computed
    Taken on
    2026-11-07
    Reported in
    USD
    • Computed from the 10-K for 2026, filed 2026-09-14
    • Computed from the 10-K for 2026, filed 2026-09-14
    • Computed from the 10-K for 2026, filed 2026-09-14
    • Computed from the 10-K for 2026, filed 2026-09-14
    • Computed from the 10-K for 2026, filed 2026-09-14

What it pays out

n/a

We do not hold this figure for this company, so there is nothing to place.

more, and better covered, is higher, with no cohort held

  • Dividend yieldn/a

    We do not hold this figure for this company, so there is nothing to place.

    Source
    computed
    Taken on
    2026-11-07
    Reported in
    USD
    • computed
  • Payout ration/a

    We do not hold this figure for this company, so there is nothing to place.

    Common Dividends Paid / Net Income x 100, both from the latest filed fiscal year

    Source
    computed
    Fiscal year
    2026
    Accession
    0001193125-26-390570
    Reported in
    USD
    • 10-K for 2026, filed 2026-09-14
    • Computed from the 10-K for 2026, filed 2026-09-14
    • 10-K for 2026, filed 2026-09-14

    The filing itself

  • Dividend cover ration/a

    We do not hold this figure for this company, so there is nothing to place.

    Source
    computed
    Taken on
    2026-11-07
    Reported in
    USD
    • computed

Share a finding

A link to the finding, not to you: it carries nothing about your account.

Filed figures cite the filing they come from; figures marked Market data are quotes as of the date shown. Not a recommendation and not advice.

Past figures are not a forecast. Anything we modelled is labelled as ours. You can lose money on any security.